2 results
Approved WMOCompleted
To assess the safety and performance of the Shockwave Coronary Rx Lithoplasty® System to treat calcified, stenotic, de novo coronary lesions prior to stenting.
Approved WMORecruiting
Primary: To characterize safety and tolerability of TNO155 and identify a recommended dose and regimen for future studies in adult patients with advanced solid tumors. And a recommended dose of TNO155 in combination with nazartinib in patients with…